Literature DB >> 1660822

Skeletal muscle degeneration and regeneration after injection of bothropstoxin-II, a phospholipase A2 isolated from the venom of the snake Bothrops jararacussu.

J M Gutiérrez1, J Núñez, C Díaz, A C Cintra, M I Homsi-Brandeburgo, J R Giglio.   

Abstract

A myotoxic phospholipase A2, named bothropstoxin II (BthTX-II), was isolated from the venom of the South American snake Bothrops jararacussu and the pathogenesis of myonecrosis induced by this toxin was studied in mice. BthTX-II induced a rapid increase in plasma creatine kinase levels. Histological and ultrastructural observations demonstrate that this toxin affects muscle fibers by first disrupting the integrity of plasma membrane, as "delta lesions" were the earliest morphological alteration and since the plasma membrane was interrupted or absent in many portions. In agreement with this hypothesis, BthTX-II released peroxidase entrapped in negatively charged multilamellar liposomes and behaved as an amphiphilic protein in charge shift electrophoresis, an indication that its mechanism of action might be based on the interaction and disorganization of plasma membrane phospholipids. Membrane damage was followed by a complex series of morphological alterations in intracellular structures, most of which are probably related to an increase in cytosolic calcium levels. Myofilaments became hypercontracted into dense clumps which alternated with cellular spaces devoid of myofibrillar material. Later on, myofilaments changed to a hyaline appearance with a more uniform distribution. Mitochondria were drastically affected, showing high amplitude swelling, vesiculation of cristae, formation of flocculent densities, and membrane disruption. By 24 hr, abundant polymorphonuclear leucocytes and macrophages were observed in the interstitial space as well as inside necrotic fibers. Muscle regeneration proceeded normally, as abundant myotubes and regenerating myofibers were observed 7 days after BthTX-II injection. By 28 days regenerating fibers had a diameter similar to that of adult muscle fibers, although they presented two distinctive features: central location of nuclei and some fiber splitting. This good regenerative response may be explained by the observation that BthTX-II does not affect blood vessels, nerves, or basal laminae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660822     DOI: 10.1016/0014-4800(91)90002-f

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  14 in total

1.  Differential Macrophage Subsets in Muscle Damage Induced by a K49-PLA2 from Bothrops jararacussu Venom Modulate the Time Course of the Regeneration Process.

Authors:  Priscila Andrade Ranéia E Silva; Adriana da Costa Neves; Cristiani Baldo da Rocha; Ana Maria Moura-da-Silva; Eliana L Faquim-Mauro
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

2.  Preliminary X-ray crystallographic studies of BthTX-II, a myotoxic Asp49-phospholipase A2 with low catalytic activity from Bothrops jararacussu venom.

Authors:  L C Corrêa; D P Marchi-Salvador; A C O Cintra; A M Soares; M R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-24

3.  Crystallization and preliminary X-ray diffraction studies of BmooPLA2-I, a platelet-aggregation inhibitor and hypotensive phospholipase A2 from Bothrops moojeni venom.

Authors:  Guilherme H M Salvador; Daniela P Marchi-Salvador; Lucas B Silveira; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-07-19

4.  Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice.

Authors:  M Lopes-Ferreira; J Núñez; A Rucavado; S H Farsky; B Lomonte; Y Angulo; A M Moura Da Silva; J M Gutiérrez
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

5.  Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms.

Authors:  Patrícia S Shimabuku; Carlos A H Fernandes; Angelo J Magro; Tássia R Costa; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-01-22

6.  Delayed local inflammatory response induced by Thalassophryne nattereri venom is related to extracellular matrix degradation.

Authors:  Alessandra Pareja-Santos; Tania Cristina Saraiva; Erica Pereira Costa; Marinilce Fagundes Santos; Telma Tenorio Zorn; Valdenia Maria Oliveira Souza; Monica Lopes-Ferreira; Carla Lima
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

7.  Crystallization and preliminary X-ray diffraction analysis of three myotoxic phospholipases A2 from Bothrops brazili venom.

Authors:  Carlos A H Fernandes; Elaine C G Gartuzo; Ivan Pagotto; Edson J Comparetti; Salomón Huancahuire-Vega; Luis Alberto Ponce-Soto; Tássia R Costa; Sergio Marangoni; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

8.  Aged skeletal muscle retains the ability to fully regenerate functional architecture.

Authors:  Antonio S J Lee; Judy E Anderson; Josephine E Joya; Stewart I Head; Nalini Pather; Anthony J Kee; Peter W Gunning; Edna C Hardeman
Journal:  Bioarchitecture       Date:  2013-07-01

9.  Pulsed ultrasound therapy accelerates the recovery of skeletal muscle damage induced by Bothrops jararacussu venom.

Authors:  J Saturnino-Oliveira; M A Tomaz; T F Fonseca; G A Gaban; M Monteiro-Machado; M A Strauch; B L Cons; S Calil-Elias; A M B Martinez; P A Melo
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

10.  Biochemical characterization and pharmacological properties of new basic PLA2 BrTX-I isolated from Bothrops roedingeri (Roedinger's Lancehead) Mertens, 1942, snake venom.

Authors:  Mauricio Aurelio Gomes Heleno; Paulo Aparecido Baldasso; Luis Alberto Ponce-Soto; Sérgio Marangoni
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.